Xcout IntelSign inSubscribe

Solaris Pharma competitors & alternatives

PharmaceuticalsUnited States

The 12 closest competitors and alternatives to Solaris Pharma among pharmaceuticals companies — ranked by similarity to what Solaris Pharma actually does, not by market-cap band.

12Competitors listed

Subscribe to see Solaris Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Solaris Pharma

Solaris Pharma Corporation is a specialty pharmaceutical company founded in 2014 and located in Bridgewater, New Jersey.

Solaris Pharma at a glance

Solaris Pharma is a pharmaceuticals company headquartered in United States. It has raised at least $23.4M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round raised $10M in December 2019. Xcout tracks 8 named people at Solaris Pharma, including Shalin Jani (President & CEO).

Solaris Pharma leadership

  • Shalin JaniPresident & CEO
  • Kamlesh AminVice President, AR&D
  • Joe LinSr. Director of Finance
  • Kamal MehtaAssociate Director of Quality Assurance
  • Rob MattisonSr. Director, Commercial Operations & Sales
  • Romit JaniSr. Director of Formulation Development

2 more named people on record for Solaris Pharma, with roles, board committees and tenure — see the full roster →

Solaris Pharma funding rounds

At least $23.4M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:

DateRoundAmountInvestors
SEC Form D filing$10M—
SEC Form D filingUndisclosed—
SEC Form D filing$13.4M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Solaris Pharma competitors

Ranked by semantic similarity — how close each company is to Solaris Pharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Amneal Pharmaceuticals, Inc.AMRX · PharmaceuticalsBridgewater, United States
67% matchPublicAI 0/100Green 0/100

Similar pharmaceuticals company

Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a diverse portfolio of complex pharmaceutical formulations. This includes oral solid doses, injectable solutions, ophthalmic preparations, liquid medications, topical applications, softgels, inhalants, and transdermal patches, all catering to a broad spectrum of medical needs. Within the Specialty division, the company concentrates on the advancement, marketing, sales, and distribution of proprietary branded pharmaceuticals. Key therapeutic areas for this segment include neurological conditions, endocrine disorders, and parasitic ailments, among others. Notable offerings include Emverm, a chewable tablet prescribed for single or mixed parasitic infections such as pinworm and various hookworms; Rytary, designed for the management of Parkinson's disease; and Unithroid, used in treating hypothyroidism. The AvKARE segment primarily serves governmental entities, particularly the Department of Defense and the Department of Veterans Affairs, supplying them with pharmaceuticals, medical and surgical supplies, and related services. Additionally, this segment engages in the bulk distribution of bottled and unit-dose pharmaceuticals under its AvKARE and AvPAK brands, alongside medical and surgical items. It also manages the packaging and large-scale distribution of medications and nutritional supplements for its retail and institutional clientele. Products from Amneal reach consumers through a network comprising wholesale suppliers, third-party distributors, hospitals, large pharmacy chains, and independent drugstores. Its operational footprint extends across the United States, India, Ireland, and other international markets. Established in 2002, the company was initially incorporated as Atlas Holdings, Inc., before adopting the name Amneal Pharmaceuticals, Inc. in 2018. Its corporate headquarters are situated in Bridgewater, New Jersey.

Market cap$5.8B
Employees8,300
Amneal Pharmaceuticals, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Solaris Pharma and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Solaris Pharmaand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →